Dong Quai Side Effects

Reported Dong Quai side effects

Dong Quai is generally well-tolerated at traditional doses (3-15g dried root equivalent daily) and typical supplement doses (500-2000mg extract daily), but several safety concerns require attention — most importantly bleeding risk, which is the dominant safety issue for this herb. Common mild side effects: Gastrointestinal symptoms: Nausea, stomach upset, cramping, diarrhea, and occasional appetite changes. Dong Quai has a warming energetic nature in TCM terms; some users find it gastrically irritating particularly on empty stomach. Taking with food reduces GI effects. Mild sweating or feeling warm: Consistent with Dong Quai's classification as a warming herb; typically modest and tolerable. Mild headache: Occasional; usually resolves with continued use or dose reduction. Changes in blood pressure: Generally modest hypotension is possible given vasodilatory effects; clinically significant blood pressure changes are uncommon at normal doses. Mild increase in menstrual flow: Consistent with traditional use — some users note heavier or longer menstrual bleeding. Clinically significant menorrhagia warrants discontinuation and medical evaluation. Significant adverse effects: Increased bleeding risk (the most important safety issue): Dong Quai's anticoagulant and antiplatelet effects can cause clinically significant bleeding, particularly when combined with pharmaceutical anticoagulants (warfarin, apixaban, rivaroxaban, dabigatran, edoxaban), antiplatelet agents (aspirin, clopidogrel, ticagrelor, prasugrel), NSAIDs in chronic high doses, or other bleeding-risk-elevating substances. Case reports document INR elevations and bleeding events with warfarin + Dong Quai combinations. Patients on any anticoagulant therapy should avoid Dong Quai; patients considering Dong Quai use should discuss with their physician if on any cardiovascular or antiplatelet medication. Photosensitivity reactions: The coumarin content (particularly furanocoumarins like psoralen, angelicin, bergapten) can cause photosensitization — exaggerated sunburn reactions, phototoxic dermatitis, or pigmentation changes with sun exposure during Dong Quai use. Users should practice sun protection (sunscreen, protective clothing) particularly at higher doses or with outdoor activities. Potential uterine stimulation: Case-level concerns about uterine stimulant effects have led to pregnancy contraindication. The smooth muscle effects are complex (both stimulation and relaxation depending on context), making a conservative "avoid in pregnancy" recommendation prudent. Allergic and contact dermatitis reactions: Apiaceae family allergy (shared with celery, carrot, parsley, fennel) can manifest as reactions to Dong Quai. Rare but documented. Hormone-sensitive condition concerns: Despite the Hirata 1997 data showing no clear estrogenic effects, the ambiguity in the literature about Dong Quai's estrogenicity warrants caution in hormone-sensitive cancers (breast, ovarian, endometrial), endometriosis, uterine fibroids, and similar conditions. Precautionary avoidance is reasonable. Population-specific concerns: Pregnancy: Contraindicated. Uterine stimulant concerns and coumarin content make pregnancy use inadvisable. Lactation: Generally not recommended. Safety data in nursing is limited; some TCM practitioners use Dong Quai in post-partum recovery formulas but under supervision; unsupervised supplement use is not recommended during lactation. Children: Not recommended due to limited pediatric safety data. Pre-surgical patients: Discontinue at least 2 weeks before elective surgery given bleeding risk. Bleeding disorders (hemophilia, von Willebrand disease, thrombocytopenia): Avoid or use only under hematologist supervision. Peptic ulcer disease, gastritis, IBD: Caution due to gastrointestinal and bleeding effects. Hormone-sensitive conditions: Avoid as precaution. Liver disease: Caution given potential hepatic effects of coumarins and CYP enzyme interactions. Thyroid disorders: Limited data but caution warranted given general hormonal interaction concerns. Drug interactions (major): Warfarin, coumarin anticoagulants: Major interaction; potentiates anticoagulant effect; documented case reports of INR elevation and bleeding. Avoid combination. Direct oral anticoagulants (DOACs): Apixaban, rivaroxaban, dabigatran, edoxaban. Theoretically concerning; avoid combination. Antiplatelet agents: Aspirin, clopidogrel, prasugrel, ticagrelor. Potential additive bleeding risk. NSAIDs: Chronic or high-dose NSAIDs combined with Dong Quai may increase bleeding risk. Heparin and low-molecular-weight heparins: Additive anticoagulant effect; avoid. Selective serotonin reuptake inhibitors (SSRIs): Some SSRIs have antiplatelet effects; combination with Dong Quai theoretically increases bleeding risk. Drug interactions (moderate concern): Hormonal contraceptives: Theoretical interference with contraceptive efficacy (limited data); unclear clinical significance. Hormone replacement therapy (HRT): Theoretical interactions given Dong Quai's traditional "female ginseng" framing; limited data. CYP3A4 substrates: Possible interactions through cytochrome P450 modulation; check specific medications with pharmacist. Antihypertensive medications: Possible additive hypotensive effects; monitor blood pressure. Thyroid medications: Limited data but caution warranted. Herb-herb interactions: Other antiplatelet/anticoagulant herbs: Ginkgo biloba, garlic at high doses, fish oil at high doses, nattokinase, turmeric/curcumin at high doses, vitamin E at high doses. Avoid stacking multiple bleeding-risk herbs. Hormonally-active herbs: Black cohosh, red clover, chasteberry (Vitex), soy isoflavones. Consider one at a time rather than combining. Sedative/hypnotic herbs: Valerian, kava, passionflower. No specific interaction documented but prudent to monitor. Quality and contamination concerns: Heavy metal contamination: Chinese herbal products have been subject to heavy metal contamination concerns; prefer products with documented heavy metal testing. Species substitution: Dong Quai can be substituted with other Angelica species (A. archangelica, A. dahurica, A. acutiloba — Japanese dong quai, different properties) in low-quality products. DNA authentication or microscopy preferred. Sulfur dioxide processing: Some Chinese herb suppliers use sulfur dioxide for preservation; sensitive individuals may react. Prefer non-sulfured products. Adulteration with pharmaceutical agents: Less common than for testosterone-marketed herbs but possible; third-party testing helps. Monitoring recommendations: Baseline: Complete blood count (CBC), INR if on any anticoagulant or with bleeding history, liver function tests During use: Monitor for bleeding signs (excessive bruising, gum bleeding, nosebleeds, heavy menstrual bleeding, blood in urine or stool) Anticoagulated patients: INR checks more frequently than usual when starting, stopping, or changing Dong Quai use Before surgery: Discontinue at least 2 weeks prior Long-term use: Periodic CBC and LFTs reasonable When to discontinue immediately: Unexpected bleeding or bruising Significant INR elevation (in warfarin users) Signs of allergic reaction (rash, angioedema, anaphylaxis) Severe GI symptoms Photosensitivity reactions Pregnancy discovery Before any surgical procedure

When to continue, reduce, or stop Dong Quai

Dong Quai contraindications

Dong Quai is contraindicated in multiple important clinical situations, with bleeding risk being the dominant safety issue. The following contraindications and cautions should be carefully observed: Absolute contraindications: Pregnancy: Contraindicated. Traditional TCM classifies Dong Quai as potentially abortifacient; smooth muscle effects on uterus are context-dependent but conservative avoidance is appropriate. Discontinue immediately if pregnancy is discovered; avoid in all trimesters. Lactation: Generally contraindicated for self-directed use. Traditional post-partum formulas contain Dong Quai but are practitioner-supervised; unsupervised supplement use during breastfeeding is not recommended. Current use of pharmaceutical anticoagulants: Warfarin (coumarin anticoagulant — direct additive effect), direct oral anticoagulants (apixaban, rivaroxaban, dabigatran, edoxaban), heparin, low-molecular-weight heparins, fondaparinux. Strong contraindication given case-report-documented bleeding risk. Bleeding disorders: Hemophilia, von Willebrand disease, platelet function disorders, thrombocytopenia, hemorrhagic conditions. Strong contraindication. Active bleeding: Do not use if actively bleeding from any source (GI bleeding, gynecological bleeding of uncertain cause, post-surgical bleeding, etc.). Pre-surgical period: Discontinue at least 2 weeks before any elective surgery; 2-4 weeks preferred for major surgery or procedures with high bleeding risk. Hormone-sensitive cancers (active): Breast cancer (particularly ER+), ovarian cancer, endometrial cancer, hormone-sensitive prostate cancer in men. Despite Dong Quai's estrogenicity being controversial and probably weak, precautionary avoidance is appropriate in active disease. Strong cautions (avoid or use only with physician supervision): History of hormone-sensitive cancer: Even in remission, caution warranted. Chronic antiplatelet therapy: Daily aspirin, clopidogrel, prasugrel, ticagrelor. Increased bleeding risk; physician consultation before use. Chronic NSAID use: Particularly at higher doses or in users with other bleeding risk factors. Recent surgery or injury: Wait until fully healed before considering use. Peptic ulcer disease: Avoid due to GI irritation and bleeding risk. Inflammatory bowel disease (active): Caution due to potential GI effects. Liver disease: Caution due to potential CYP enzyme interactions and coumarin hepatic effects. Thyroid disorders: Limited data; physician coordination recommended. Diabetes: Monitor blood glucose; possible modest effects. Hypertension or hypotension: Monitor blood pressure given vasodilatory effects. Uterine fibroids, endometriosis, or other hormone-sensitive gynecological conditions: Precautionary avoidance given theoretical hormonal effects. Drug interactions (major): Warfarin: Well-documented case reports of INR elevation and bleeding; strong contraindication Direct oral anticoagulants: Theoretical additive effect; avoid Heparin and LMWH: Additive anticoagulant effect; avoid Antiplatelet agents: Aspirin, clopidogrel, etc.; additive bleeding risk Drug interactions (moderate): NSAIDs (ibuprofen, naproxen, celecoxib, etc.): Particularly chronic or high-dose use SSRIs: Sertraline, fluoxetine, paroxetine, etc. — some antiplatelet effect from SSRIs, additive with Dong Quai SNRIs: Venlafaxine, duloxetine Hormonal contraceptives: Theoretical interference; data unclear Hormone replacement therapy: Theoretical additive or competitive effects Antihypertensive medications: Monitor blood pressure Thyroid medications: Possible interactions; coordinate CYP3A4 substrates: Some medications metabolized through CYP3A4; consult pharmacist CYP2C9 substrates: Similar caution Herb-herb interactions: Other anticoagulant/antiplatelet herbs: Avoid stacking Ginkgo biloba — antiplatelet effects Garlic at high doses Fish oil at high doses (>3g/day EPA+DHA) Nattokinase Turmeric/curcumin at high pharmaceutical doses Vitamin E at high doses (>400 IU daily long-term) Salvia miltiorrhiza (Dan Shen) Feverfew at high doses Ginger at very high doses (culinary doses safe) Boswellia at high doses Multiple hormonally-active herbs: Black cohosh, red clover, soy isoflavones, chasteberry (Vitex) — consider one at a time rather than stacking all Hepatotoxic herbs: Kava, comfrey, pennyroyal, chaparral — avoid stacking with Dong Quai given coumarin content Photosensitizing herbs: St. John's Wort, other coumarin-rich herbs — additive photosensitivity risk Population-specific contraindications: Children and adolescents: Not recommended due to limited pediatric data and hormonal concerns Elderly patients on polypharmacy: Increased interaction and bleeding risks; cautious approach Patients with complex cardiovascular disease: Coordinate with cardiologist Patients with coagulation monitoring requirements: If use is considered despite other cautions, more frequent INR/coagulation monitoring is essential Immunocompromised patients: Limited data on immune interactions; caution advised Patients planning conception in next 2-3 months: Discontinue to allow washout before conception attempts Monitoring during use: Watch for bleeding signs: unexpected bruising, gum bleeding, nosebleeds, heavy/prolonged menstrual flow, blood in urine/stool/sputum, melena Watch for photosensitivity: exaggerated sunburn, skin reactions with sun exposure Monitor menstrual patterns (for reproductive-age women) Blood pressure (given vasodilator effects) Baseline and periodic CBC INR if on any interacting medication When to discontinue immediately: Any bleeding event requiring medical attention Unusual/prolonged bruising Pregnancy discovery Before any surgery or invasive procedure New diagnosis of any contraindicating condition Any significant allergic reaction Severe GI symptoms Photosensitivity reactions Any adverse effect disrupting daily life Bottom line: Dong Quai's safety profile is dominated by bleeding risk — the combination of coumarin content, antiplatelet effects, and documented case reports of INR elevation with warfarin co-administration make this the central safety concern. Users with any condition requiring anticoagulation, any bleeding disorder, any surgical planning, or who are pregnant or potentially pregnant should not use Dong Quai. For healthy users without these contraindications, Dong Quai at modest doses (500-1000mg standardized extract daily) is generally well-tolerated, but the herb is best used within traditional TCM combination frameworks under practitioner guidance rather than as a standalone Western supplement.

Why vendor quality drives Dong Quai side-effect frequency

Research-compound communities consistently report that adverse-event frequency tracks with source quality. Three reasons: (1) impurity profiles vary by lab (residual synthesis byproducts can trigger reactions); (2) mislabeled mass means actual dose can be 50-150% of stated dose; (3) reconstitution-grade water and capping methodology affect long-term storage stability. COA-verified vendors with published HPLC data minimize all three failure modes. Check a vendor's COA record and Trust Score before you buy.

Dong Quai side effects FAQ

Research-use disclaimer. All safety information on this page summarizes published research literature and community-reported reactions. It is not medical advice and not authorization for human consumption. Always consult a licensed practitioner before any compound enters a clinical context. Compounds linked from this page are sold for research-use only.
Affiliate disclosure. See our affiliate disclosure .